Advertisement
Advertisement
Fidelity Disruptive Medicine Fund (FRXNX)
Nasdaq - Nasdaq Delayed Price. Currency in USD
Follow
As of 08:06AM EDT. Market open.
Advertisement
| Previous Close | 11.05 |
| YTD Return | 4.70% |
| Expense Ratio (net) | 1.00% |
| Category | Health |
| Last Cap Gain | 4.00 |
| Morningstar Rating | ★★★★★ |
| Morningstar Risk Rating | N/A |
| Sustainability Rating |
| Net Assets | 64.39M |
| Beta (5Y Monthly) | N/A |
| Yield | N/A |
| 5y Average Return | N/A |
| Holdings Turnover | N/A |
| Last Dividend | N/A |
| Average for Category | N/A |
| Inception Date | Apr 16, 2020 |
- GlobeNewswire
Industry Leaders Welcome New Study of Save Foods’ Treatment Showing Extended Shelf-Life of Mangos While Virtually Eliminating Post-Harvest Pesticides
Following the mango study results, Galilee Export, Israel’s second-largest fresh produce exporter, plans to use Save Foods’ solution for its mangos in the upcoming 2022-2023 season Miami, FL, June 21, 2022 (GLOBE NEWSWIRE) -- Save Foods (NASDAQ: SVFD) (FSE:80W) (“Save Foods” or the “Company”), an agri-food tech company specializing in eco crop protection that helps to reduce food waste and ensure food safety, announced results of an independent study that shows Save Foods’ treatment can extend t
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
